Ethics approval and consent to participate
The study was conducted following the Declaration of Helsinki, was approved by the Research Ethics Committee of the University of Burgundy (CERUBFC-2022–09-29–031) and was registered at ClinicalTrials.gov (ID: NCT05744011). Each person likely to take part in this research was informed and a summary document on the main characteristics of the study was given during the inclusion visit. The written informed consent statement was given for immediate signature or after a reflection period. In case of doubt about the patient's ability to give consent, caregivers and the healthcare team were asked to help measure the expression of the person's autonomy and presumed wishes. In the case of persons under legal protection, the magistrate and the competent judge were informed, and authorization was requested.